Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 198.00
-10.00 (-4.81%)
Sep 16, 2025, 1:35 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 322.61 billion as of September 16, 2025. Its market cap has increased by 276.87% in one year.
Market Cap
322.61B
Enterprise Value
313.22B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
198.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 322.61B, an increase of 3,953.72%. That is a compound annual growth rate of 289.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 322.61B | 241.88% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 186.40B |
| Bora Pharmaceuticals Co., LTD. | 87.62B |
| Lotus Pharmaceutical | 49.18B |
| Lumosa Therapeutics | 48.10B |
| Oneness Biotech | 34.10B |
| Polaris Group | 29.12B |
| Center Laboratories | 27.28B |
| Pell Bio-Med Technology | 25.70B |